Iht Wealth Management, LLC Heron Therapeutics, Inc. Transaction History

Iht Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.35 - $12.6 $100,408 - $151,515	-12,025 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$14.49 - $20.72 $130,931 - $187,225	-9,036 Reduced 42.9%	12,025 $195,000
Q4 2020 Feb 17, 2021	BUY	$14.61 - $22.14 $133,915 - $202,935	9,166 Added 77.06%	21,061 $446,000
Q2 2020 Aug 14, 2020	BUY	$10.89 - $21.47 $129,536 - $255,385	11,895 New	11,895 $175,000
Q1 2018 May 15, 2018	SELL	$18.43 - $28.8 $0 - $0	0 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$14.8 - $18.85 $636 - $810	-43 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$14.65 - $16.85 $629 - $724	43	43 $1,000

193

129M

94.7K

148K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $227M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.